BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹310 Cr | ₹258 Cr | ₹240 Cr | ₹176 Cr | ₹100 Cr |
What is the latest Total Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹310 Cr |
| Mar2024 | ₹258 Cr |
| Mar2023 | ₹240 Cr |
| Mar2022 | ₹176 Cr |
| Mar2021 | ₹100 Cr |
How is Total Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹310 Cr | 20.13 | |
| Mar2024 | ₹258 Cr | 7.79 | |
| Mar2023 | ₹240 Cr | 35.81 | |
| Mar2022 | ₹176 Cr | 77.04 | |
| Mar2021 | ₹100 Cr | - | |
Compare Total Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹110.5 Cr | -1.8% | -17.6% | -61.1% | Stock Analytics | |
| ADANI ENTERPRISES | ₹282,109.0 Cr | -1.3% | 11.3% | 1.7% | Stock Analytics | |
| REDINGTON | ₹18,758.7 Cr | -7.3% | -4.1% | 7.7% | Stock Analytics | |
| HONASA CONSUMER | ₹9,951.4 Cr | 1.3% | 12.5% | 39.4% | Stock Analytics | |
| MMTC | ₹9,243.0 Cr | -2.9% | -4.2% | 13.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,243.4 Cr | -8% | -0.2% | 28.1% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -1.8% |
-17.6% |
-61.1% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses